Teva Pharmaceutical Industries reported $-576M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Aspen Pharmacare ZAR 1.47B 4.94B Dec/2025
Cipla INR 7.89B 2.34B Jun/2026
Dr.Reddys Laboratories INR 4.44B 2.23B Jun/2026
Guangzhou Baiy CNY 312.16M 1.47B Jun/2026
Jiangsu Hengrui CNY 2.18B 99.1M Jun/2026
Kalbe Farma IDR 1.03T 372.52B Mar/2026
Richter Gedeon HUF 65.28B 21.94B Mar/2026
Sh Fosun Pharma CNY 850.64M 20.18M Jun/2026
Sun Pharmaceuticals INR 28.95B 1.81B Jun/2026
Teva Pharmaceutical Industries USD -576M 945M Jun/2026